Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Crivelli, Joseph J. | - |
dc.contributor.author | Kim, Peter S. | - |
dc.contributor.author | Choi, Il-Kyu | - |
dc.contributor.author | Yun, Chae-Ok | - |
dc.contributor.author | Wares, Joanna R. | - |
dc.date.accessioned | 2021-08-03T08:20:44Z | - |
dc.date.available | 2021-08-03T08:20:44Z | - |
dc.date.created | 2021-07-26 | - |
dc.date.issued | 2014-12-01 | - |
dc.identifier.issn | 1043-0342 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/41614 | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MARY ANN LIEBERT, INC | - |
dc.title | Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics | - |
dc.type | Conference | - |
dc.contributor.affiliatedAuthor | Yun, Chae-Ok | - |
dc.identifier.wosid | 000346352600024 | - |
dc.identifier.bibliographicCitation | 8th International Conference on Oncolytic Virus Therapeutics, pp.A11 - A12 | - |
dc.relation.isPartOf | 8th International Conference on Oncolytic Virus Therapeutics | - |
dc.relation.isPartOf | HUMAN GENE THERAPY | - |
dc.citation.title | 8th International Conference on Oncolytic Virus Therapeutics | - |
dc.citation.startPage | A11 | - |
dc.citation.endPage | A12 | - |
dc.citation.conferencePlace | US | - |
dc.citation.conferencePlace | Lincoln Coll & Examinat Sch, Oxford, ENGLAND | - |
dc.citation.conferenceDate | 2014-04-10 | - |
dc.type.rims | CONF | - |
dc.description.journalClass | 1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.